Skip to main content
. 2022 Sep 13;10(1):89–96. doi: 10.1093/nop/npac068

Table 2.

Neurocognition, Neurobehavioral Symptoms, Fatigue, Sleep Disturbance, and Depressive Symptoms at Time of Diagnosis

Variable Measure Mean (SD) N Below Cutoff , n (%)
Neurocognition WTAR 107.12 (7.36) 43
HVLT-R Total −1.43 (0.93) 45 19 (42.22)*
HVLT-R Delayed Recall −1.36 (1.11) 45 24 (53.33)*
HVLT-R Retention −0.73 (1.38) 45 14 (31.11)*
COWA −0.94 (1.33) 42 17 (40.47)*
TMT A −1.11 (2.53) 45 11 (24.44)*
TMT B −1.51 (1.53) 45 23 (51.11)*
Above cutoff , n (%)
Neurobehavioral Symptoms FrSBe Apathy Before 46.93 (10.31) 45 4 (8.89)
FrSBe Disinhibition Before 47.71 (12.26) 45 3 (6.67)
FrSBe Executive Dys. Before 49.62 (11.00) 45 4 (8.89)
FrSBe Total Before 47.84 (10.70) 45 3 (6.67)
FrSBe Apathy After 54.44 (14.89) 45 12 (26.67)
FrSBe Disinhibition After 52.62 (15.49) 45 10 (22.22)
FrSBe Executive Dys. After 56.76 (15.56) 45 15 (33.33)
FrSBe Total After 55.78 (17.10) 45 12 (26.67)
Fatigue FSI Severity 3.35 (1.89) 42 24 (57.14)
FSI Interference 2.43 (2.22) 42
FSI Frequency 3.13 (2.07) 42
FSI Total 2.80 (1.84) 42
Sleep PSQI Sleep Efficiency 2.21 (1.85) 39
PSQI Perceived Sleep Quality 2.63 (2.10) 40
PSQI Daily Disturbances 2.03 (1.13) 38
PSQI Global Score 6.78 (3.45) 40 28 (70.00)
Depressive Symptoms HADS Depression Scale 4.18 (3.08) 44 7 (15.91)

Notes: A cutoff of z≤-1.5 was used to characterize impairment on individual neurocognitive tests. In addition, the following cutoff scores were used to characterize clinically elevated symptoms: ≥3 for FSI Severity, ≥5 for PSQI Global Score, and (≥7) for HADS Depression Scale.

Abbreviations: WTAR = Wechsler Adult Reading Test Predicted WAIS-IV Full Scale IQ Score; HVLT-R =Hopkins Verbal Learning Test-Revised; COWA = Controlled Oral Word Association; TMT = Trail Making Test; FrSBe = Frontal Systems Behavior Scale; Executive Dys. = Executive Dysfunction; FSI = Fatigue Symptom Inventory; PSQI = The Pittsburgh Sleep Quality Index; HADS = Hospital Anxiety and Depression Scale.

*t-test, P < .01.